Viewing Study NCT03221166


Ignite Creation Date: 2025-12-24 @ 4:11 PM
Ignite Modification Date: 2026-03-05 @ 12:06 AM
Study NCT ID: NCT03221166
Status: TERMINATED
Last Update Posted: 2020-09-04
First Post: 2017-07-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Thalidomide Versus Infliximab in New Onset Crohn's Disease With Poor Prognostic Factors
Sponsor: IRCCS Burlo Garofolo
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Crohn Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Children View
None Crohn disease View
None Thalidomide View
None Mucosal healing View